Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: Implications for combination TKI therapy

Research output: Contribution to journalLetter

24 Citations (Scopus)
Original languageEnglish
Pages (from-to)658-660
Number of pages3
JournalLeukemia
Volume24
Issue number3
DOIs
Publication statusPublished - 1 Jan 2010

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this